Fund shareholders of ELICIO THERAPEUTICS INC
ISIN US28657F1030 · United States · LEI 254900EE2QKYD5SGI956
- Fund shareholders
- 15
- Of which ETFs
- 1 14 other funds
- Value held
- ≈ 7.6M $ 7.4M $ · 189.8K €
- Share of capital
- 2.5 % of 26.3M shares on Aug 11, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 384,801 | 4.1M $ | 0.00 % | 1.46 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 120,683 | 1.3M $ | 0.00 % | 0.46 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 58,772 | 763.4K $ | 0.00 % | 0.22 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 27,993 | 299.2K $ | 0.02 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 21,289 | 276.5K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 15,172 | 197.1K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 14,357 | 186.5K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 10,496 | 112.2K $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 6,579 | 70.3K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 6,575 | 70.3K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 1,956 | 20.9K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 1,303 | 13.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 81.4K € | 0.22 % | as of Dec 31, 2025 ↗ | ||
| FERMION FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 74.5K € | 0.77 % | as of Dec 31, 2025 ↗ | ||
| NORTH CAPE INVERSIONES, S.A., SICAV ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 33.8K € | 0.27 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| FERMION FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 0.77 % | as of Dec 31, 2025 ↗ |
| NORTH CAPE INVERSIONES, S.A., SICAV ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 0.27 % | as of Dec 31, 2025 ↗ |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 0.22 % | as of Dec 31, 2025 ↗ |
| Small Cap Core Fund Northern Funds | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 12 | 0 | 669,976 | +18.2 % |
| 2026Q1 | 12 | -1 | 566,766 | +3.0 % |
| 2025Q4 | 13 | +2 | 550,185 | -0.7 % |
| 2025Q3 | 11 | +1 | 553,981 | +34.8 % |
| 2025Q2 | 10 | 0 | 411,004 | +22.2 % |
| 2025Q1 | 10 | -1 | 336,219 | -5.0 % |
| 2024Q4 | 11 | +2 | 353,840 | +19.4 % |
| 2024Q3 | 9 | -4 | 296,251 | +5.2 % |
| 2024Q2 | 13 | -1 | 281,629 | +27.3 % |
| 2024Q1 | 14 | -1 | 221,153 | +23.3 % |
| 2023Q4 | 15 | 179,422 |
Institutional managers
43 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Knoll Capital Management, LLC | 630,915 | 6.7M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 244,814 | 2.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 135,164 | 1.4M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 121,631 | 1.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 92,762 | 991.6K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 74,512 | 796.5K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 70,804 | 756.9K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 59,734 | 638.6K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 57,818 | 618.1K $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 56,442 | 603.4K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 50,620 | 541.1K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 50,597 | 540.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 33,769 | 361K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 32,404 | 346.4K $ | as of Mar 31, 2026 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 30,051 | 321.2K $ | as of Mar 31, 2026 |
| CM Management, LLC | 25,000 | 267.3K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 21,611 | 231 $ | as of Mar 31, 2026 |
| Hudson Bay Capital Management LP | 20,208 | 216K $ | as of Mar 31, 2026 |
| Brevan Howard Capital Management LP | 17,401 | 186K $ | as of Mar 31, 2026 |
| Quadrature Capital Ltd | 16,912 | 180.8K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 15,978 | 170.8K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 15,333 | 163.9K $ | as of Mar 31, 2026 |
| MEYER HANDELMAN CO | 13,899 | 148.6K $ | as of Mar 31, 2026 |
| KINGSWOOD WEALTH ADVISORS, LLC | 13,800 | 147.5K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 13,785 | 147.4K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of ELICIO THERAPEUTICS INC". https://titelia.com/en/stocks/elicio-therapeutics-inc-US28657F1030